Cogniforce

CogniForce provides the key nutrients for cognitive function and brain health maintenance. A standardized root extract of the adaptogenic herb ashwagandha known as KSM-66, and L-theanine work to reduce stress hormones and promote more clear and relaxed thinking. Ginkgo leaf extract increases blood flow to the brain, leading to more responsive and accurate memory. A complex of B-vitamins promotes normal metabolism of homocysteine. Multiple clinical trials have shown that maintaining healthy homocysteine levels reduces brain volume loss that occurs naturally with aging.*

Nourish your mind with these 10 brain-feeding nutrients

Let your brain feast on the 10 nutrients it desperately craves.

The Cogniforce brain-feeding supplement is specifically designed to promote...

  • Faster memory recall*
  • Heightened awareness*
  • Enhanced concentration*


You might assume these things are only affected by age.

However, with the correct nutrition you can help reverse the effects of aging and keep your brain running like new … effectively rebuilding your brain.*

The first ingredient, Acetyl L-Carnitine (ALC), is a neurotransmitter building block which provides a wide range of brain health benefits.*

An Italian study showed that elderly people who took ACL performed significantly better on memory tests.*

That’s because they add to the deep mass of neurons which control memory. This is the first ingredient your brain gorges on.

But Cogniforce still hasn’t dished up the second course.

Feel the effects of L-theanine - shown to increase your alpha brain-wave activity. These are the “feel-good” brain-waves you experience when you’re relaxed, alert and clear.* Oxford University noticed it has effect after just 30 minutes.

And leave room for Cogniforce’s Gingko Leaf Extract. This remarkable ingredient is linked with increased blood-flow to the brain. It is also shown to boost microcirculation - helping carry these nutrients through its tiniest capillaries. Rounding out the formula are several B vitamins associated with improved memory performance: Folic Acid, Vitamin B6 and B12.*

Is your brain hungry for these nutrients?

Why not try Cogniforce and see for yourself?

If you don’t feel as sharp, focused and alert as you’ve ever been, simply return the bottle for a full refund.*

  1. Arrigo A, Casale RBuonocore MCiano C. Int J Clin Pharmacol Res. 1990;10(1-2):133-7.
  2. Benedict CR, Anderson GHSole MJ. Am J Clin Nutr. 1983 Sep;38(3):429-35.
  3. Bianchetti A, Rozzini RTrabucchi M. Curr Med Res Opin. 2003;19(4):350-3.
  4. Biswajit Auddy, PhD; Jayaram Hazra, PhD; Achintya Mitra, MD;
  5. Bonavita E. Int J Clin Pharmacol Ther Toxicol. 1986 Sep;24(9):511-6.
  6. Brooks JO 3rd, Yesavage JACarta ABravi D. Int Psychogeriatr. 1998 Jun;10(2):193-203.
  7. Bruce Abedon, PhD; Shibnath Ghosal, PhD. 2008. Withania somnifera.
  8. Bryan J, Calvaresi EHughes D. J Nutr. 2002 Jun;132(6):1345-56.
  9. de Jager CA, Oulhaj AJacoby RRefsum HSmith AD. Int J Geriatr Psychiatry. 2012 Jun;27(6):592-600.
  10. Deijen JB, van der Beek EJOrlebeke JFvan den Berg H. Psychopharmacology (Berl). 1992;109(4):489-96.
  11. Dodd FL, Kennedy DORiby LMHaskell-Ramsay CF. Psychopharmacology (Berl). 2015 Jul;232(14):2563-76.
  12. Erickson KI, Suever BLPrakash RSColcombe SJMcAuley EKramer AF. Brain Res. 2008 Mar 14; 1199:20-6.
  13. Garzya G, Corallo DFiore ALecciso GPetrelli GZotti C. Drugs Exp Clin Res. 1990;16(2):101-6.
  14. Gessner B, Voelp AKlasser M. Arzneimittelforschung. 1985;35(9):1459-65.
  15. Gomez-Ramirez M, Kelly SPMontesi JLFoxe JJ. Brain Topogr. 2009 Jun;22(1):44-51.
  16. Herrschaft H, Nacu ALikhachev SSholomov IHoerr RSchlaefke S. J Psychiatr Res. 2012 Jun;46(6):716-23.
  17. Ihl R, Tribanek MBachinskaya NGOTADAY Study Group. Pharmacopsychiatry. 2012 Mar;45(2):41-6.
  18. Kado DM, Karlamangla ASHuang MHTroen ARowe JWSelhub JSeeman TE. Am J Med. 2005 Feb;118(2):161-7.
  19. Kaschel R. Phytomedicine. 2011 Nov 15;18(14):1202-7. 
  20. Kennedy DO, Haskell CFMauri PLScholey AB. Hum Psychopharmacol. 2007 Jun;22(4):199-210.
  21. Kennedy DO, Jackson PAHaskell CFScholey AB. Hum Psychopharmacol. 2007 Dec;22(8):559-66.
  22. Kimura K, Ozeki MJuneja LROhira H. Biol Psychol. 2007 Jan;74(1):39-45.
  23. LaSala GS, McKeever RGPatel UOkaneku JVearrier DGreenberg MI. Clin Toxicol (Phila). 2015 Feb;53(2):108-12.
  24. Le Bars PL, Katz MMBerman NItil TMFreedman AMSchatzberg AF. JAMA. 1997 Oct 22-29;278(16):1327 32.
  25. Le Bars PL, Kieser MItil KZ. Dement Geriatr Cogn Disord. 2000 Jul-Aug;11(4):230-7.
  26. Loos UMarklein GScholl HSchwabe HK. Pneumologie. 1990 Feb;44 Suppl 1:312-3.
  27. Louwman MW, van Dusseldorp Mvan de Vijver FJThomas CMSchneede JUeland PMRefsum Hvan Staveren WA. Am J Clin Nutr. 2000 Sep;72(3):762-9.
  28. Lu K, Gray MAOliver CLiley DTHarrison BJBartholomeusz CFPhan KLNathan PJ. Hum Psychopharmacol. 2004 Oct;19(7):457-65.
  29. Mahoney CR, Castellani JKramer FMYoung ALieberman HR. Physiol Behav. 2007 Nov 23;92(4):575-82.
  30. Malaguarnera M, Gargante MPCristaldi EColonna VMessano MKoverech ANeri SVacante MCammalleri LMotta M. Arch Gerontol Geriatr. 2008 Mar-Apr;46(2):181-90. 
  31. Mashayekh A, Pham DLYousem DMDizon MBarker PBLin DD. Neuroradiology. 2011 Mar;53(3):185-91.
  32. Mayer G, Kröger MMeier-Ewert K. Neuropsychopharmacology. 1996 Nov;15(5):456-64.
  33. Mayeux R, Sano M. N Engl J Med. 1999 Nov 25;341(22):1670-9.
  34. McNulty H, Dowey le RCStrain JJDunne AWard MMolloy AMMcAnena LBHughes JPHannon-Fletcher MScott JM. Circulation. 2006 Jan 3;113(1):74-80.
  35. Mix JA, Crews WD Jr. Hum Psychopharmacol. 2002 Aug;17(6):267-77.
  36. Montgomery SA, Thal LJAmrein R. Int Clin Psychopharmacol. 2003 Mar;18(2):61-71.
  37. Nasab NM, Bahrammi MANikpour MRRahim FNaghibis SN. J Pak Med Assoc. 2012 Jul;62(7):677-80.
  38. Nobre AC, Rao AOwen GN. Asia Pac J Clin Nutr. 2008;17 Suppl 1:167-8.
  39. O'Brien C, Mahoney CTharion WJSils IVCastellani JW. Physiol Behav. 2007 Feb 28;90(2-3):301-7.
  40. Passeri M, Cucinotta DBonati PAIannuccelli MParnetti LSenin U. Int J Clin Pharmacol Res. 1990;10(1-2):75-9.
  41. Penninx BW, Guralnik JMFerrucci LFried LPAllen RHStabler SP. Am J Psychiatry. 2000 May;157(5):715-21.
  42. Pingali U, Pilli R, Fatima N. Pharmacognosy Res. 2014 Jan;6(1):12-8.
  43. Rai GS, Shovlin CWesnes KA. Curr Med Res Opin. 1991;12(6):350-5.
  44. Rasmussen DD, Ishizuka BQuigley MEYen SS. J Clin Endocrinol Metab. 1983 Oct;57(4):760-3.
  45. Rebouche CJ. Ann N Y Acad Sci. 2004 Nov; 1033:30-41.
  46. Rump TJ, Abdul Muneer PMSzlachetka AMLamb AHaorei CAlikunju SXiong HKeblesh JLiu JZimmerman MCJones JDonohue TM JrPersidsky YHaorah J. Free Radic Biol Med. 2010 Nov 30;49(10):1494-504.
  47. Salvioli G, Neri M. Drugs Exp Clin Res. 1994;20(4):169-76.
  48. Santos RF, Galduróz JCBarbieri ACastiglioni MLYtaya LYBueno OF. Pharmacopsychiatry. 2003 Jul;36(4):127-33.
  49. Scholey A, Ossoukhova AOwen LIbarra APipingas AHe KRoller MStough C. Psychopharmacology (Berl). 2010 Oct;212(3):345-56.
  50. Smith AD, Smith SMde Jager CAWhitbread PJohnston CAgacinski GOulhaj ABradley KMJacoby RRefsum H. PLoS One. 2010 Sep 8;5(9): e12244.
  51. Tempesta E, Troncon RJaniri LColusso LRiscica PSaraceni GGesmundo ECalvani MBenedetti NPola P. Int J Clin Pharmacol Res. 1990;10(1-2):101-7.
  52. Tomassini V, Pozzilli COnesti EPasqualetti PMarinelli FPisani AFieschi C. J Neurol Sci. 2004 Mar 15;218(1-2):103-8.
  53. Triantafyllou NI, Nikolaou CBoufidou FAngelopoulos ERentzos MKararizou EEvangelopoulos MEVassilopoulos D. Parkinsonism Relat Disord. 2008;14(4):321-5.
  54. Vermeulen RC, Scholte HR. Psychosom Med. 2004 Mar-Apr;66(2):276-82.
  55. Vogiatzoglou A, Refsum HJohnston CSmith SMBradley KMde Jager CBudge MMSmith AD. Neurology. 2008 Sep 9;71(11):826-32.
  56. Yao Z, Drieu KPapadopoulos V. Brain Res. 2001 Jan 19;889(1-2):181-90.
  57. Yoto A, Motoki MMurao SYokogoshi H. J Physiol Anthropol. 2012 Oct 29;31:28.
  58. Zhao MX, Dong ZHYu ZHXiao SYLi YM. Zhong Xi Yi Jie He Xue Bao. 2012 Jun;10(6):628-34.